General Information of the Compound
Compound ID |
CP0004216
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
(S)-3-(azetidin-2-ylmethoxy)pyridine
Show/Hide
|
||||||||||||||||||
Synonyms |
(S)-3-(AZETIDIN-2-YLMETHOXY)PYRIDINE
161416-98-4
3-((S)-1-Azetidin-2-ylmethoxy)-pyridine
3-(2(s)-azetidinylmethoxy)pyridine
3-[(2S)-azetidin-2-ylmethoxy]pyridine
3-[[(2S)-azetidin-2-yl]methoxy]pyridine
A 85380
A-159470
A-85380
AC1NSJQT
AKOS030230435
BDBM50049750
CHEMBL59986
GTPL5460
NCGC00387223-01
Pyridine, 3-(2-azetidinylmethoxy)-, (S)-
Pyridine, 3-[(2S)-2-azetidinylmethoxy]-
SCHEMBL676026
ZINC3805142
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C9H12N2O
|
||||||||||||||||||
Molecular Weight |
164.208
|
||||||||||||||||||
Canonical SMILES |
C(Oc1cccnc1)[C@@H]1CCN1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C9H12N2O/c1-2-9(6-10-4-1)12-7-8-3-5-11-8/h1-2,4,6,8,11H,3,5,7H2/t8-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
XKFMBGWHHBCWCD-QMMMGPOBSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02515, Neuronal acetylcholine receptor subunit alpha-3
Protein ID: PT01846, Neuronal acetylcholine receptor subunit alpha-7
Clinical Information about the Compound
Drug 1 ( A-85380 )
Drug Name | A-85380 |
---|